1 Report Prologue
2 Market Introduction
2.1 Scope of Study 17
2.2 Research Objective 17
2.3 Assumptions & Limitations 17
2.3.1 Assumptions 17
2.3.2 Limitations 17
3 Research Methodology
3.1 Primary Research Methodology 19
3.2 Secondary Research Methodology 20
3.3 Market Share Analysis 21
3.4 Trade Analysis 21
3.5 Market Pricing Approach 21
4 Market Dynamics
4.1 Introduction 23
4.2 Drivers 24
4.2.1 Rising Prevalence of Autism Disorder and Pervasive Developmental Disorder Have Fueled the Growth of the Market.(PDD) 24
4.2.2 Expected Approvals of Off-Label Drugs to Treat Autism Disorder Has Driven the Market Growth 25
4.2.3 Rising government or privately held societies taking initiatives to create the awareness about the disease 26
4.3 Restraints 27
4.3.1 Weak Product Pipeline of First Drugs for Autism 27
4.3.2 Unknown Etiology and Pathophysiology of the Disorder Prevent Effective Treatment Options 28
4.4 Opportunities 29
4.4.1 Rising Investments by Venture Non-Pharmacology Activities 29
4.5 Mega Trends 30
4.6 Macroeconomic Indicators
5 Market Factor Analysis
5.1 Porter’s Five Forces Model 32
5.1.1 Bargaining Power of Suppliers 33
5.1.2 Bargaining Power of Buyers 33
5.1.3 Threat of New Entrants 33
5.1.4 Threat of Substitutes 33
5.1.5 Intensity of Rivalry 33
5.2 Value Chain Analysis 34
5.2.1 R&D 34
5.2.2 Manufacturing 34
5.2.3 Distribution & Sales 34
5.2.4 Post-Sales Monitoring 35
5.3 Pricing Analysis 36
5.4 Investment Opportunity Analysis 36
5.5 Demand & Supply: Gap Analysis 36
6 Autism Disorder & Treatment Market, By Type
6.1 Introduction 39
6.2 Asperger Syndrome 40
6.3 Pervasive Developmental Disorders (PDD) 40
7 Autism Disorder & Treatment Market, By Treatment Type
7.1 Introduction 42
7.2 Expert Opinion: Oxytocin 42
7.3 ABA (applied behavioral analysis) 43
7.4 Hyperbaric oxygen therapy 44
7.5 Chelation therapy 44
7.6 Oxytocin therapy 44
8 Autism Disorder & Treatment Market, By Drugs
8.1 Introduction 46
8.2 Selective Serotonin Reuptake Inhibitors (SSRIs) 47
8.3 Anti-convulsants 48
8.4 Stimulants 48
8.5 Anti-psychotic 48
9 Global Autism Disorder & Treatment Market, By Region
9.1 Introduction 50
9.2 Americas 51
Autism Disorder & Treatment Market, By Type
Autism Disorder & Treatment Market, By Treatment Type
Autism Disorder & Treatment Market, By Drugs
9.3 North America 54
Autism Disorder & Treatment Market, By Type
Autism Disorder & Treatment Market, By Treatment Type
Autism Disorder & Treatment Market, By Drugs
9.3.1 U.S. 54
Autism Disorder & Treatment Market, By Type
Autism Disorder & Treatment Market, By Treatment Type
Autism Disorder & Treatment Market, By Drugs
9.4 Canada 55
Autism Disorder & Treatment Market, By Type
Autism Disorder & Treatment Market, By Treatment Type
Autism Disorder & Treatment Market, By Drugs
9.4.1 South America 56
Autism Disorder & Treatment Market, By Type
Autism Disorder & Treatment Market, By Treatment Type
Autism Disorder & Treatment Market, By Drugs
9.5 Europe 57
Autism Disorder & Treatment Market, By Type
Autism Disorder & Treatment Market, By Treatment Type
Autism Disorder & Treatment Market, By Drugs
9.5.1 Germany 60
Autism Disorder & Treatment Market, By Type
Autism Disorder & Treatment Market, By Treatment Type
Autism Disorder & Treatment Market, By Drugs
9.5.2 France 61
Autism Disorder & Treatment Market, By Type
Autism Disorder & Treatment Market, By Treatment Type
Autism Disorder & Treatment Market, By Drugs
9.5.3 U.K. 62
Autism Disorder & Treatment Market, By Type
Autism Disorder & Treatment Market, By Treatment Type
Autism Disorder & Treatment Market, By Drugs
9.5.4 Italy 63
Autism Disorder & Treatment Market, By Type
Autism Disorder & Treatment Market, By Treatment Type
Autism Disorder & Treatment Market, By Drugs
9.5.5 Spain 64
Autism Disorder & Treatment Market, By Type
Autism Disorder & Treatment Market, By Treatment Type
Autism Disorder & Treatment Market, By Drugs
9.5.6 Rest of Western Europe 65
Autism Disorder & Treatment Market, By Type
Autism Disorder & Treatment Market, By Treatment Type
Autism Disorder & Treatment Market, By Drugs
9.5.7 Eastern Europe 66
Autism Disorder & Treatment Market, By Type
Autism Disorder & Treatment Market, By Treatment Type
Autism Disorder & Treatment Market, By Drugs
9.6 Asia Pacific 67
Autism Disorder & Treatment Market, By Type
Autism Disorder & Treatment Market, By Treatment Type
Autism Disorder & Treatment Market, By Drugs
9.6.1 Japan 69
Autism Disorder & Treatment Market, By Type
Autism Disorder & Treatment Market, By Treatment Type
Autism Disorder & Treatment Market, By Drugs
9.6.2 China 70
Autism Disorder & Treatment Market, By Type
Autism Disorder & Treatment Market, By Treatment Type
Autism Disorder & Treatment Market, By Drugs
9.6.3 India 71
Autism Disorder & Treatment Market, By Type
Autism Disorder & Treatment Market, By Treatment Type
Autism Disorder & Treatment Market, By Drugs
9.6.4 Australia 72
Autism Disorder & Treatment Market, By Type
Autism Disorder & Treatment Market, By Treatment Type
Autism Disorder & Treatment Market, By Drugs
9.6.5 Republic of Korea 73
Autism Disorder & Treatment Market, By Type
Autism Disorder & Treatment Market, By Treatment Type
Autism Disorder & Treatment Market, By Drugs
9.6.6 Rest of Asia Pacific 74
Autism Disorder & Treatment Market, By Type
Autism Disorder & Treatment Market, By Treatment Type
Autism Disorder & Treatment Market, By Drugs
9.7 Middle East & Africa 76
Autism Disorder & Treatment Market, By Type
Autism Disorder & Treatment Market, By Treatment Type
Autism Disorder & Treatment Market, By Drugs
9.7.1 U.A.E. 78
Autism Disorder & Treatment Market, By Type
Autism Disorder & Treatment Market, By Treatment Type
Autism Disorder & Treatment Market, By Drugs
9.7.2 Saudi Arabia 79
Autism Disorder & Treatment Market, By Type
Autism Disorder & Treatment Market, By Treatment Type
Autism Disorder & Treatment Market, By Drugs
9.7.3 Oman 80
Autism Disorder & Treatment Market, By Type
Autism Disorder & Treatment Market, By Treatment Type
Autism Disorder & Treatment Market, By Drugs
9.7.4 Kuwait 81
Autism Disorder & Treatment Market, By Type
Autism Disorder & Treatment Market, By Treatment Type
Autism Disorder & Treatment Market, By Drugs
9.7.5 Qatar 82
Autism Disorder & Treatment Market, By Type
Autism Disorder & Treatment Market, By Treatment Type
Autism Disorder & Treatment Market, By Drugs
9.7.6 Rest of the Middle East & Africa 83
Autism Disorder & Treatment Market, By Type
Autism Disorder & Treatment Market, By Treatment Type
Autism Disorder & Treatment Market, By Drugs
10 Competitive Landscape
10.1 Company Market Share Analysis 86
10.1.1 Introduction 86
10.2 Competitive Landscape 87
10.2.1 Introduction 87
10.3 Recent Developments, 2013–2018 88
11 Company Profiles
11.1 Pfizer Inc. 91
11.1.1 Company Overview 91
11.1.2 Financials 91
11.1.3 Products 91
11.1.4 Strategy 91
11.1.5 Key Developments 91
11.2 Allergan, Plc 92
11.2.1 Company Overview 92
11.2.2 Financials 92
11.2.3 Products 92
11.2.4 Strategy 92
11.2.5 Key Developments 92
11.3 Eli Lilly and Company 93
11.3.1 Company Overview 93
11.3.2 Financials 93
11.3.3 Products 93
11.3.4 Strategy 93
11.3.5 Key Developments 93
11.4 Bristol-Myers Squibb Company 94
11.4.1 Company Overview 94
11.4.2 Financials 94
11.4.3 Products 94
11.4.4 Strategy 94
11.4.5 Key Developments 94
11.5 Sun Pharmaceutical Industries Ltd. 95
11.5.1 Company Overview 95
11.5.2 Financials 95
11.5.3 Products 95
11.5.4 Strategy 95
11.5.5 Key Developments 95
11.6 Johnson & Johnson Services, Inc. 96
11.6.1 Company Overview 96
11.6.2 Financials 96
11.6.3 Products 96
11.6.4 Strategy 96
11.6.5 Key Developments 96
11.7 Teva Pharmaceutical Industries Ltd. 97
11.7.1 Company Overview 97
11.7.2 Financials 97
11.7.3 Products 97
11.7.4 Strategy 97
11.7.5 Key Developments 97
11.8 Merck & Co. Inc 98
11.8.1 Company Overview 98
11.8.2 Financials 98
11.8.3 Products 98
11.8.4 Strategy 98
11.8.5 Key Developments 98
11.9 Novartis AG 99
11.9.1 Company Overview 99
11.9.2 Financials 99
11.9.3 Products 99
11.9.4 Strategy 99
11.9.5 Key Developments 99
11.10 Otsuka Holdings Co. Ltd 100
11.10.1 Company Overview 100
11.10.2 Financials 100
11.10.3 Products 100
11.10.4 Strategy 100
11.10.5 Key Developments 100
11.11 Consern Pharma Private Limited 101
12 Conclusion
12.1 Key Findings 103
12.1.1 CEO’s Viewpoint 103
12.1.2 Key Companies to Watch 103
12.1.3 Prediction of Dietary Supplements in an Age of Personalized Nutrition Industry 103
13 Appendix
13.1 Discussion Blue Print 105
13.2 Expert Opinion: Oxytocin 107
13.3 References 107